Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.
about
A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessmentScreening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety EvaluationBig data in chemical toxicity research: the use of high-throughput screening assays to identify potential toxicantsA model for aryl hydrocarbon receptor-activated gene expression shows potency and efficacy changes and predicts squelching due to competition for transcription co-activatorsEditor's Highlight: Screening ToxCast Prioritized Chemicals for PPARG Function in a Human Adipose-Derived Stem Cell Model of AdipogenesisEditor's Highlight: Development of an In vitro Assay Measuring Uterine-Specific Estrogenic Responses for Use in Chemical Safety AssessmentA predictive data-driven framework for endocrine prioritization: a triazole fungicide case studyCERAPP: Collaborative Estrogen Receptor Activity Prediction ProjectIdentification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays.International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposesFutureTox II: in vitro data and in silico models for predictive toxicologyAroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens.Induction of the Estrogenic Marker Calbindn-D₉k by OctamethylcyclotetrasiloxaneA Bisphenol by Any Other Name...Advances in the Development and Validation of Test Methods in the United States.Improving the human hazard characterization of chemicals: a Tox21 updateOn the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens.Contribution of new technologies to characterization and prediction of adverse effects.Development of estrogen receptor beta binding prediction model using large sets of chemicals.The unsteady state and inertia of chemical regulation under the US Toxic Substances Control Act.A Reduced Transcriptome Approach to Assess Environmental Toxicants Using Zebrafish Embryo Test.Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.Identification of potential aryl hydrocarbon receptor ligands by virtual screening of industrial chemicals.Transcriptomic and phenotypic profiling in developing zebrafish exposed to thyroid hormone receptor agonists.
P2860
Q23909862-CCDB6BCC-3522-43B7-8213-DF3C72044B69Q26860299-9D33D0BF-C798-4F1E-AF26-7159D696BEBBQ27008504-D204E46A-C4A4-4CBE-ABA2-5106F9ECCEFEQ28395513-8DE494D4-33FD-45DC-8822-A9FA02D0B22FQ28817923-FC33DC2C-DA70-4D30-BAEA-759779D229CDQ28822339-06FCFF9D-C330-4D8A-BC2A-10A063FE480CQ28828276-567476DD-2D4C-4958-8D5A-E32FA6BE5148Q28830914-8293AF41-94FE-435D-BC0A-75E13A62E763Q34740499-66120307-C2E7-4C08-AEB3-3614B7E750E7Q34993998-D8617D1B-1C46-45C4-B585-BA346555208AQ35024730-61CAC182-6F8C-4526-ABCB-52828C04B316Q35055252-7BC57F10-05E7-4A8D-BCA6-0B249065393CQ36112971-3714850C-75DB-4848-A538-19B62F6117EEQ36324193-77CE2BB4-13C8-4AA7-AF07-2738C9890F03Q36521168-7C32803F-6847-448A-9C43-A9C94347B358Q36657693-2CD91C7C-C3C4-4669-9CBF-FE6B3580FE7CQ36984065-F4F7854F-4D5D-4F2C-BF5D-A83EBB90832FQ37158812-2572D8CD-55A7-490C-8F44-253A119C519AQ38329939-1D246D85-623B-49DA-9B2C-7403C8038719Q47096067-D39FE8C3-D75B-488C-BB4B-770CB1C6578AQ47146138-6EBB9803-160D-4550-B3F3-298C3C270E3BQ47761700-5DF11F6C-56EB-44AC-8170-CB62F1337C95Q47947469-02C09CC6-25DF-4A26-A881-BB453FD443C2Q48321338-A67FEC65-39D6-4F8A-959B-F8A9812D1BE5Q49847881-29C5A3E7-E3A7-4610-96CE-3CA8D56AD70B
P2860
Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Using in vitro high throughput ...... ndocrine-disrupting chemicals.
@ast
Using in vitro high throughput ...... ndocrine-disrupting chemicals.
@en
type
label
Using in vitro high throughput ...... ndocrine-disrupting chemicals.
@ast
Using in vitro high throughput ...... ndocrine-disrupting chemicals.
@en
prefLabel
Using in vitro high throughput ...... ndocrine-disrupting chemicals.
@ast
Using in vitro high throughput ...... ndocrine-disrupting chemicals.
@en
P2093
P2860
P50
P356
P1476
Using in vitro high throughput ...... endocrine-disrupting chemicals
@en
P2093
David J Dix
Keith A Houck
Keith W McLaurin
Matthew T Martin
Menghang Xia
Ruili Huang
Thomas B Knudsen
P2860
P356
10.1289/EHP.1205065
P577
2012-09-28T00:00:00Z